blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3651735

EP3651735 - PREPARATION COMPRISING VONOPRAZAN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.02.2023
Database last updated on 14.11.2024
FormerThe patent has been granted
Status updated on  11.03.2022
FormerGrant of patent is intended
Status updated on  04.11.2021
FormerRequest for examination was made
Status updated on  17.04.2020
FormerThe international publication has been made
Status updated on  18.01.2019
Formerunknown
Status updated on  28.08.2018
Most recent event   Tooltip27.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 30.10.2024  [2024/44]
Applicant(s)For all designated states
Takeda Pharmaceutical Company Limited
1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045 / JP
[2020/21]
Inventor(s)01 / FUJII, Hiroyuki
c/o TAKEDA PHARMACEUTICAL COMPANY LIMITED
17-85 Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka 532-0024 / JP
02 / SUZUKI, Akira
c/o TAKEDA CONSUMER HEALTHCARE COMPANY LIMITED
17-85 Jusohonmachi 2-chome
Yodogawa-ku
Osaka-shi Osaka 532-0024 / JP
 [2020/21]
Representative(s)Jones, Nicholas Andrew
Withers & Rogers LLP
2 London Bridge
London SE1 9RA / GB
[2022/15]
Former [2020/21]Jones, Nicholas Andrew
Withers & Rogers LLP
4 More London Riverside
London, SE1 2AU / GB
Application number, filing date18755569.309.07.2018
[2020/21]
WO2018JP26416
Priority number, dateJP2017013504610.07.2017         Original published format: JP 2017135046
[2020/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019013310
Date:17.01.2019
Language:EN
[2019/03]
Type: A1 Application with search report 
No.:EP3651735
Date:20.05.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 17.01.2019 takes the place of the publication of the European patent application.
[2020/21]
Type: B1 Patent specification 
No.:EP3651735
Date:13.04.2022
Language:EN
[2022/15]
Search report(s)International search report - published on:EP17.01.2019
ClassificationIPC:A61K9/00, A61K9/20, A61K9/50, A61K31/4439
[2020/21]
CPC:
A61K9/0056 (EP,KR,US); A61K9/2081 (EP,KR); A61K9/14 (US);
A61K31/4439 (EP,KR,US); A61K47/12 (US); A61K9/2013 (KR);
A61K9/2018 (EP,KR,US); A61K9/2027 (US); A61K9/2054 (EP,US);
A61K9/2846 (KR); A61K9/2886 (KR); A61K9/5026 (EP);
A61K9/5078 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/21]
Extension statesBA23.12.2019
ME23.12.2019
Validation statesMD23.12.2019
TitleGerman:PRÄPARAT MIT VONOPRAZAN[2020/21]
English:PREPARATION COMPRISING VONOPRAZAN[2020/21]
French:PRÉPARATION COMPRENANT DU VONOPRAZAN[2020/21]
Entry into regional phase23.12.2019National basic fee paid 
23.12.2019Designation fee(s) paid 
23.12.2019Examination fee paid 
Examination procedure23.12.2019Examination requested  [2020/21]
23.12.2019Date on which the examining division has become responsible
27.08.2020Amendment by applicant (claims and/or description)
05.11.2021Communication of intention to grant the patent
03.03.2022Fee for grant paid
03.03.2022Fee for publishing/printing paid
03.03.2022Receipt of the translation of the claim(s)
Opposition(s)16.01.2023No opposition filed within time limit [2023/12]
Fees paidRenewal fee
10.07.2020Renewal fee patent year 03
14.07.2021Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.07.2018
AL13.04.2022
AT13.04.2022
CY13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
MC13.04.2022
MK13.04.2022
MT13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SI13.04.2022
SK13.04.2022
SM13.04.2022
IE09.07.2022
LU09.07.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
BE31.07.2022
CH31.07.2022
LI31.07.2022
IS13.08.2022
PT16.08.2022
[2024/44]
Former [2024/24]HU09.07.2018
AL13.04.2022
AT13.04.2022
CY13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
MC13.04.2022
MK13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SI13.04.2022
SK13.04.2022
SM13.04.2022
IE09.07.2022
LU09.07.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
BE31.07.2022
CH31.07.2022
LI31.07.2022
IS13.08.2022
PT16.08.2022
Former [2024/23]AL13.04.2022
AT13.04.2022
CY13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
MC13.04.2022
MK13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SI13.04.2022
SK13.04.2022
SM13.04.2022
IE09.07.2022
LU09.07.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
BE31.07.2022
CH31.07.2022
LI31.07.2022
IS13.08.2022
PT16.08.2022
Former [2024/20]AL13.04.2022
AT13.04.2022
CY13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
MC13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SI13.04.2022
SK13.04.2022
SM13.04.2022
IE09.07.2022
LU09.07.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
BE31.07.2022
CH31.07.2022
LI31.07.2022
IS13.08.2022
PT16.08.2022
Former [2023/33]AL13.04.2022
AT13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
MC13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SI13.04.2022
SK13.04.2022
SM13.04.2022
IE09.07.2022
LU09.07.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
BE31.07.2022
CH31.07.2022
LI31.07.2022
IS13.08.2022
PT16.08.2022
Former [2023/25]AL13.04.2022
AT13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
MC13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SI13.04.2022
SK13.04.2022
SM13.04.2022
LU09.07.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
BE31.07.2022
CH31.07.2022
LI31.07.2022
IS13.08.2022
PT16.08.2022
Former [2023/21]AL13.04.2022
AT13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
MC13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SK13.04.2022
SM13.04.2022
LU09.07.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
CH31.07.2022
LI31.07.2022
IS13.08.2022
PT16.08.2022
Former [2023/17]AL13.04.2022
AT13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
MC13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SK13.04.2022
SM13.04.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
IS13.08.2022
PT16.08.2022
Former [2023/11]AT13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
MC13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SK13.04.2022
SM13.04.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
IS13.08.2022
PT16.08.2022
Former [2023/09]AT13.04.2022
CZ13.04.2022
DK13.04.2022
EE13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
NL13.04.2022
PL13.04.2022
RO13.04.2022
RS13.04.2022
SE13.04.2022
SK13.04.2022
SM13.04.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
IS13.08.2022
PT16.08.2022
Former [2023/07]AT13.04.2022
DK13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
NL13.04.2022
PL13.04.2022
RS13.04.2022
SE13.04.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
IS13.08.2022
PT16.08.2022
Former [2022/51]AT13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
NL13.04.2022
PL13.04.2022
RS13.04.2022
SE13.04.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
IS13.08.2022
PT16.08.2022
Former [2022/50]AT13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
NL13.04.2022
PL13.04.2022
RS13.04.2022
SE13.04.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
PT16.08.2022
Former [2022/49]AT13.04.2022
FI13.04.2022
HR13.04.2022
LT13.04.2022
LV13.04.2022
NL13.04.2022
SE13.04.2022
BG13.07.2022
NO13.07.2022
GR14.07.2022
PT16.08.2022
Former [2022/47]AT13.04.2022
FI13.04.2022
LT13.04.2022
NL13.04.2022
SE13.04.2022
NO13.07.2022
PT16.08.2022
Former [2022/44]NL13.04.2022
Cited inInternational search[YD]WO2007026916  (TAKEDA PHARMACEUTICAL [JP], et al);
 [YD]WO2010013823  (TAKEDA PHARMACEUTICAL [JP], et al);
 [Y]CN105030725  (DISHA PHARMACEUTICAL GROUP CO);
 [Y]CN105030720  (DISHA PHARMACEUTICAL GROUP CO);
 [Y]CA2994073  (TAKEDA PHARMACEUTICALS CO [JP])
by applicantJPS61213201
 WO2007026916
 WO2010013823
 JP2017135046
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.